Literature DB >> 2970222

The influence of body weight on lipoprotein lipids in patients with polycystic ovary syndrome.

R A Wild1, M J Bartholomew.   

Abstract

Lipoprotein lipid and androgen profiles were compared after a 12-hour fast that involved 13 women with polycystic ovary syndrome and 13 who did not have the syndrome. All women were matched for percent ideal body weight. As expected, patients with polycystic ovary syndrome had significantly higher luteinizing hormone--to--follicle-stimulating hormone ratios, higher testosterone levels, higher free testosterone levels, higher dehydroepiandrosterone sulfate levels, and lower testosterone-estradiol-binding globulin binding capacity than the other women. Patients with polycystic ovary syndrome had significantly higher mean serum triglyceride levels, very-low-density lipoprotein cholesterol levels, and lower high-density lipoprotein cholesterol levels. Differences in body weight do not explain the male pattern of lipoprotein lipid concentrations in women with polycystic ovary syndrome. The association of hyperandrogenism with lipoprotein lipid abnormalities should be evaluated in regard to the influence of endogenous sex steroids on differences between the sexes in incidence of cardiovascular disease.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2970222     DOI: 10.1016/s0002-9378(88)80099-1

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  14 in total

Review 1.  Cardiometabolic aspects of the polycystic ovary syndrome.

Authors:  Harpal S Randeva; Bee K Tan; Martin O Weickert; Konstantinos Lois; John E Nestler; Naveed Sattar; Hendrik Lehnert
Journal:  Endocr Rev       Date:  2012-07-24       Impact factor: 19.871

Review 2.  Insulin resistance, the metabolic syndrome, diabetes, and cardiovascular disease risk in women with PCOS.

Authors:  H J Teede; S Hutchison; S Zoungas; C Meyer
Journal:  Endocrine       Date:  2006-08       Impact factor: 3.633

Review 3.  Obstructive sleep apnea and metabolic dysfunction in polycystic ovary syndrome.

Authors:  Katie Nitsche; David A Ehrmann
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2010-10       Impact factor: 4.690

4.  Dyslipidemia and metabolic syndrome in the sisters of women with polycystic ovary syndrome.

Authors:  Susan Sam; Richard S Legro; Rhonda Bentley-Lewis; Andrea Dunaif
Journal:  J Clin Endocrinol Metab       Date:  2005-05-17       Impact factor: 5.958

5.  Testosterone-induced vasorelaxation in the rat mesenteric arterial bed is mediated predominantly via potassium channels.

Authors:  Patcharin Tep-areenan; David A Kendall; Michael D Randall
Journal:  Br J Pharmacol       Date:  2002-02       Impact factor: 8.739

Review 6.  Role of GnRH drive in the pathophysiology of polycystic ovary syndrome.

Authors:  M P Leondires; S L Berga
Journal:  J Endocrinol Invest       Date:  1998 Jul-Aug       Impact factor: 4.256

Review 7.  Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan.

Authors:  H Teede; A Deeks; L Moran
Journal:  BMC Med       Date:  2010-06-30       Impact factor: 8.775

8.  Comparison of CT and dual-energy DEXA using a modified trunk compartment in the measurement of abdominal fat.

Authors:  James T Lane; Lynn R Mack-Shipman; Joseph C Anderson; Timothy E Moore; Judi M Erickson; Timothy C Ford; Julie A Stoner; Jennifer L Larsen
Journal:  Endocrine       Date:  2005-08       Impact factor: 3.925

9.  Lipid Profile in Adolescent Girls with Type 1 Diabetes Mellitus and Hyperandrogenemia.

Authors:  Agnieszka Zachurzok; Grazyna Deja; Aneta Gawlik; Agnieszka Drosdzol-Cop; Katarzyna Klimek; Ewa Malecka-Tendera
Journal:  Int J Endocrinol       Date:  2016-04-27       Impact factor: 3.257

10.  Genetic and gene expression analyses of the polycystic ovary syndrome candidate gene fibrillin-3 and other fibrillin family members in human ovaries.

Authors:  Mark J Prodoehl; Nicholas Hatzirodos; Helen F Irving-Rodgers; Zhen Z Zhao; Jodie N Painter; Theresa E Hickey; Mark A Gibson; William E Rainey; Bruce R Carr; Helen D Mason; Robert J Norman; Grant W Montgomery; Raymond J Rodgers
Journal:  Mol Hum Reprod       Date:  2009-08-19       Impact factor: 4.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.